Siponimod

	Use attributes for filter !
Molar mass	516. 26 g/mol
Formula	C29H35F3N2O3
ATC code	L04AA42 (WHO)
Other names	BAF-312
Trade name	Mayzent
License data	EMA
	DailyMed
	US
	FDA
Music groups	Fingolimod
	Cladribine
	Ocrelizumab
Date of Reg.	2020-04-06 06:45:33
Date of Upd.	2023-03-19 07:54:18
ID	2951157

Send edit request

About Siponimod

Siponimod, sold under the brand name Mayzent, is a selective sphingosine-1-phosphate receptor modulator for oral use that is used for multiple sclerosis. It is intended for once-daily oral administration.

'Major moment in MS research' as new Octopus trial starts

Apr 4,2023 8:41 am

... Under the current National Institute for Health and Care Excellence guidelines, only two drugs - Siponimod and Extavia - are approved for secondary progressive MS, and not everyone will qualify for them...